LexaGene
is a Massachusetts-based biotechnology company that develops and commercializes pathogen detection systems for pharmaceutical and research institutions... Read moreLexaGene
is a Massachusetts-based biotechnology company that develops and commercializes pathogen detection systems for pharmaceutical and research institutions... Read more
News
Feb 25, 2023
Life Care News
LexaGene: LexaGene Files for Chapter 7 Bankruptcy
Feb 21, 2023
Cision Canada
Press Release: LexaGene : IIROC Trading Halt - LXG
Feb 10, 2023
Life Care News
LexaGene: LexaGene Holdings Announces Results of February 8, 2023
Feb 08, 2023
centralcharts
Press Release: LexaGene : LexaGene Provides Update on BioPharma Sector
Feb 06, 2023
LexaGene Blog
LexaGene Blog The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants
Jan 18, 2023
MarketScreener
LexaGene: LexaGene's MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma Customers
Jan 18, 2023
Owler
Lexagene Holdings, Inc.: LexaGene's revenue changed from $165.17K in Aug 2022 to $167.46K in Nov 2022
Dec 17, 2022
Life Care News
LexaGene: BioPharma Engages LexaGene in Second Feasibility Study
Dec 07, 2022
MarketScreener
LexaGene: LexaGene : Proposes to Amend Warrants Terms - Form 8-K
Nov 22, 2022
GlobalNewswire
Press Release: LexaGene : LexaGene Successfully Completes Statement of Work for BioPharma Company
LexaGene Competitors
1
2
3
4
5
6
7
8
9
10